clinical lab test references
BiomarkersLabs.com

Lab Testing for Practitioners

BML-HMT-008heavy metals toxicologyUSA

Blood Metals Panel

The Blood Metals Panel quantifies toxic (lead, mercury, cadmium, arsenic, aluminium) and essential (copper, zinc, manganese, chromium) metals in whole blood, reflecting recent exposure and circulating status. It is ordered to screen occupational cohorts, investigate suspected toxicity, monitor chelation, and assess trace-element adequacy in at-risk populations.

9

Biomarkers

Blood (whole blood)

Sample

7–10 business days

Turnaround

No

Fasting

What is the Blood Metals test?

The Blood Metals Panel quantifies a range of essential and toxic metals in whole blood, providing a snapshot of recent or ongoing exposure and, for the essential trace elements, a window into nutritional and metabolic status. Practitioners order this panel to screen occupational cohorts at risk of heavy-metal toxicity, to investigate unexplained neurological, renal, haematological, or multisystem symptoms that raise suspicion of metal poisoning, and to monitor patients undergoing chelation or dietary intervention. Unlike urine provocation tests or hair analysis, whole-blood measurement reflects circulating metal — the biologically active compartment for acute toxicity and, for metals with short half-lives, the most reliable indicator of very recent exposure. For metals with longer tissue residence (lead, cadmium), blood and urine are complementary; for those rapidly cleared (arsenic), urine is often preferred. This panel is positioned as a screening and monitoring tool in integrative, occupational, and environmental medicine, and results must be interpreted in the context of exposure history, symptomatology, and, where appropriate, follow-up speciation or tissue imaging.

What does the Blood Metals test measure?

1
Pb(Lead (Blood))
Range: <3.5 µg/dL (adult); paediatric reference limits lower.Optimal: Public health consensus: <5 µg/dL in children, as low as achievable in all populations.µg/dL / µg/L

Lead is a toxic heavy metal with no physiological role. It binds to sulfhydryl groups in enzymes and structural proteins, interfering with haem synthesis, mitochondrial function, and cellular signalling. Blood lead reflects recent or ongoing exposure; more than 95% circulates bound to erythrocytes, with a blood half-life of approximately 30 days. Bone stores can remobilise during physiological stress, pregnancy, or periods of increased bone turnover.

Blood lead is the standard marker for recent lead exposure and is used to screen occupational and environmental exposure, guide chelation decisions, and monitor workers in lead industries. Chronic low-level exposure is associated with neurodevelopmental deficits in children and cardiovascular, renal, and neurocognitive effects in adults. No safe threshold has been established for children.

2
Hg(Mercury (Blood))
Range: <10 µg/L (general population); lower thresholds advised for reproductive-age women.Optimal: <5 µg/L in reproductive-age women; as low as achievable given neurotoxicity.µg/L / nmol/L

Blood mercury reflects primarily organic (methylmercury) exposure from fish and seafood, with a half-life of approximately 50 days. Methylmercury crosses the blood-brain barrier and placenta readily, posing neurotoxic risk. Inorganic mercury from dental amalgam or occupational sources contributes minimally to whole-blood levels but may be seen in plasma or serum fractions.

Blood mercury is ordered to assess dietary or occupational exposure and to evaluate neurological symptoms, tremor, or suspected toxicity. Elevated levels in pregnant or reproductive-age women guide dietary counselling to reduce foetal methylmercury exposure, which is associated with neurodevelopmental impairment.

3
Cd(Cadmium (Blood))
Range: <1 µg/L (non-smoker); smokers may reach 2–5 µg/L.Optimal: <0.5 µg/L; lower in non-smokers and those without occupational exposure.µg/L / nmol/L

Cadmium is a nephrotoxic and carcinogenic metal absorbed via inhalation (tobacco smoke, occupational dust) and diet (shellfish, offal, some grains). Blood cadmium reflects recent exposure with a half-life of several months, while urinary cadmium integrates long-term body burden. Cadmium binds metallothionein in erythrocytes and accumulates in renal tubules.

Blood cadmium is used to monitor recent occupational or smoking-related exposure. Chronic accumulation causes proximal tubular dysfunction (Fanconi syndrome), bone demineralisation (itai-itai disease in severe cases), and is a class I carcinogen. Practitioners order it in battery workers, smelters, and heavy smokers, or when investigating unexplained proteinuria.

4
As(Arsenic (Blood))
Range: <7 µg/L (total arsenic); speciation advisable to separate inorganic from organic.Optimal: <2 µg/L inorganic species; total arsenic variable depending on recent seafood intake.µg/L / nmol/L

Blood arsenic has a very short half-life (hours for inorganic arsenic) and reflects only acute or very recent exposure. Inorganic arsenic is metabolised to methylated forms and excreted in urine; organic arsenicals from seafood (arsenobetaine) are non-toxic and rapidly cleared. Blood total arsenic can be misleading without speciation or a concurrent urine sample.

Blood arsenic is rarely the preferred specimen for chronic exposure assessment — urine arsenic with speciation is more informative. Blood measurement is useful in acute poisoning or to confirm very recent high-level exposure. Chronic inorganic arsenic exposure causes skin changes, peripheral neuropathy, vascular disease, and increased cancer risk.

5
Al(Aluminium (Blood))
Range: <10 µg/L (general population); <20 µg/L in patients on dialysis.Optimal: <5 µg/L in the general population; tighter control in dialysis (target <20 µg/L).µg/L / nmol/L

Aluminium is ubiquitous in the environment but poorly absorbed from the gastrointestinal tract in healthy individuals. Blood aluminium reflects recent exposure and is elevated in renal failure, where diminished clearance permits accumulation, and in patients receiving aluminium-containing antacids or parenteral nutrition. Aluminium binds transferrin and distributes to bone and brain.

Blood aluminium is ordered primarily in dialysis patients, where chronic elevation can cause dialysis encephalopathy, osteomalacia, and microcytic anaemia unresponsive to iron. It is also used to investigate occupational exposure in welders and smelters, or following high-dose antacid use in renal patients.

6
Cr(III)/Cr(VI)(Chromium (Blood))
Range: <1 µg/L (general population).Optimal: <0.5 µg/L; minimise hexavalent exposure.µg/L / nmol/L

Chromium exists in trivalent (Cr³⁺) and hexavalent (Cr⁶⁺) forms. Trivalent chromium is an essential trace element involved in glucose and lipid metabolism, while hexavalent chromium is a recognised carcinogen. Blood chromium is not routinely measured for nutritional assessment; elevations reflect occupational exposure (welding, chrome plating) or contamination.

Blood chromium is ordered to assess hexavalent chromium exposure in industrial workers, where inhalation can cause lung cancer and dermatitis. Interpretation is complicated by contamination risk during collection and the inability of routine assays to distinguish Cr³⁺ from Cr⁶⁺. Nutritional chromium status is not reliably assessed by blood level.

7
Mn(Manganese (Blood))
Range: 4–15 µg/L (typical); assay- and population-dependent.Optimal: 4–10 µg/L; avoid chronic inhalation exposure above occupational limits.µg/L / nmol/L

Manganese is an essential trace element, a cofactor for superoxide dismutase and other metalloenzymes. It is tightly regulated by biliary excretion; whole-blood levels reflect recent intake and occupational inhalation. Chronic excessive exposure — especially via inhalation in welders and miners — causes accumulation in the basal ganglia and a Parkinsonian syndrome (manganism).

Blood manganese is ordered to investigate suspected neurotoxicity in workers with high inhalation exposure (welding fume, mining, battery manufacture) or in patients on long-term parenteral nutrition. Elevated levels correlate poorly with body burden because excretion is so tightly regulated, so neuroimaging (MRI T1 hyperintensity in the globus pallidus) often adds diagnostic value.

8
Cu(Copper (Blood))
Range: 70–140 µg/dL (adults); higher in women and pregnancy due to oestrogen effects on caeruloplasmin.Optimal: 80–130 µg/dL; free (non-caeruloplasmin) copper <10–15 µg/dL.µg/dL / µmol/L

Copper is an essential trace element, incorporated into caeruloplasmin (the main plasma copper-binding protein) and enzymes including cytochrome c oxidase and superoxide dismutase. Whole-blood or serum copper reflects both caeruloplasmin-bound and free (exchangeable) copper. Free copper rises in Wilson disease and can be neurotoxic and hepatotoxic.

Blood copper, interpreted with caeruloplasmin and 24-hour urinary copper, is central to the diagnosis of Wilson disease (low total copper, low caeruloplasmin, high free copper, high urinary copper) and to monitoring copper deficiency in malabsorption, prolonged parenteral nutrition, or zinc overload. Copper deficiency causes microcytic or sideroblastic anaemia, neutropaenia, and myelopathy.

9
Zn(Zinc (Blood))
Range: 70–120 µg/dL (serum/plasma); whole-blood values higher but less commonly used.Optimal: 80–110 µg/dL; correct for inflammation and albumin where possible.µg/dL / µmol/L

Zinc is an essential trace element required for more than 300 enzymes, immune function, wound healing, and DNA synthesis. Most circulating zinc is bound to albumin; inflammatory states lower serum zinc by redistributing it into tissues, so interpretation requires correlating with acute-phase markers. Whole-blood zinc includes an intracellular pool and is less influenced by inflammation.

Blood zinc is ordered to diagnose deficiency (acrodermatitis enteropathica, malabsorption, prolonged parenteral nutrition, chronic diarrhoea) and to monitor repletion. Deficiency impairs immune function, delays wound healing, and causes taste disturbance and dermatitis. Excess zinc, often from supplementation, causes copper deficiency by competitive inhibition of intestinal absorption.

Why is the Blood Metals test ordered?

  • Occupational screening of workers in smelting, battery manufacture, welding, mining, or electronics industries, where inhalation or dermal contact with toxic metals is documented
  • Investigation of suspected acute or subacute heavy-metal poisoning presenting with neurological symptoms (tremor, peripheral neuropathy, encephalopathy), renal impairment, or unexplained anaemia
  • Monitoring of patients undergoing chelation therapy for lead, mercury, or arsenic toxicity, to track blood levels and guide treatment duration
  • Assessment of trace-element status in patients on long-term parenteral nutrition, malabsorption syndromes, or restrictive diets, particularly for copper, zinc, and manganese
  • Evaluation of children with neurodevelopmental concerns and known environmental lead exposure (old housing, contaminated water, lead-based pottery)
  • Work-up of suspected Wilson disease (low copper, low caeruloplasmin) or copper deficiency (microcytic anaemia, neutropaenia, myelopathy)
  • Screening of patients with high seafood consumption or dental amalgam who report chronic fatigue, cognitive symptoms, or concern about mercury exposure
  • Baseline and follow-up in dialysis patients at risk of aluminium accumulation from water or antacids

Sample collection and turnaround

Sample type

Blood (whole blood)

Fasting required

No

Collection method

Venipuncture at patient service centre

Turnaround

7–10 business days

Collection notes

Phlebotomy required. Use trace-element–free (royal-blue top or laboratory-specified) evacuated tubes to prevent external contamination. Avoid haemolysis. Separate and process according to the laboratory's protocol; whole-blood specimens are typically stable refrigerated for several days but should be shipped promptly. Note timing relative to known exposure events for metals with short half-lives (arsenic, inorganic mercury vapour).

Specimen requirements

Whole blood in trace-element–free tube (sodium heparin or EDTA, per laboratory specification). Minimum volume approximately 3–5 mL. Do not use standard serum or plasma tubes. Reject haemolysed or clotted specimens if protocol specifies.

What can affect Blood Metals results?

elevatesRecent seafood consumption

Organic arsenic (arsenobetaine, arsenocholine) from fish and shellfish elevates total blood and urine arsenic but is non-toxic; speciation is required to separate it from inorganic (toxic) species. Mercury from fish also raises blood levels.

elevatesTobacco smoking

Cigarette smoke is a major source of cadmium and contributes to lead exposure; blood cadmium in smokers is typically two to five times that of non-smokers.

elevatesContamination during collection

Trace metals are ubiquitous; collection tubes, needles, and environmental dust can contaminate specimens. Use trace-element–free tubes (royal-blue top or equivalent) and clean technique to avoid spurious results.

variableHaemolysis

Some metals concentrate in erythrocytes (lead, arsenic to a degree), so haemolysis can alter the plasma/whole-blood distribution and produce artefactually high or low results depending on the analyte and assay.

reducesAcute-phase response and inflammation

Serum zinc and copper shift during inflammation — zinc falls as it is sequestered into tissues, and copper rises with caeruloplasmin (an acute-phase reactant). Whole-blood values are less affected but not immune.

variableTiming relative to exposure

Blood levels of metals with short half-lives (arsenic, inorganic mercury from vapour) fall rapidly after exposure ends, so the sample must be collected soon after contact. For cumulative toxins (lead, cadmium), blood integrates weeks to months of exposure.

What do Blood Metals results mean?

Elevated

Lead: occupational or environmental exposure (paint, water, battery work); consider chelation if symptomatic or >10 µg/dL in children, >25 µg/dL in adults. Mercury: dietary (methylmercury from fish) or occupational (vapour, dental); advise reduced seafood intake in reproductive-age women if >5 µg/L. Cadmium: smoking or industrial exposure; investigate renal tubular function if >2 µg/L. Arsenic: if elevated and recent seafood ruled out, consider contaminated water or occupational exposure; confirm with speciated urine. Aluminium: renal failure, dialysis, or antacid overuse; risk of encephalopathy and bone disease. Chromium: industrial hexavalent exposure (welding, plating); carcinogenic. Manganese: welding fume, mining; risk of Parkinsonian syndrome. Copper: elevated free copper with low caeruloplasmin suggests Wilson disease; high total copper with high caeruloplasmin seen in inflammation or oestrogen states. Zinc: elevated with over-supplementation; can induce copper deficiency.

Normal

Normal blood metal levels in the appropriate clinical and exposure context provide reassurance against acute or recent high-level toxicity and adequate status for the essential trace elements. They do not exclude historical exposure (tissue stores of lead or cadmium), very low-level chronic accumulation, or deficiency states best assessed by functional markers (e.g., erythrocyte zinc, urinary manganese).

Reduced

Copper: suspect Wilson disease (with low caeruloplasmin, high urinary copper) or nutritional deficiency (malabsorption, zinc overload, prolonged parenteral nutrition); causes anaemia, neutropaenia, myelopathy. Zinc: malabsorption (coeliac, Crohn), acrodermatitis enteropathica, prolonged parenteral nutrition without supplementation, or chronic diarrhoea; impairs immunity, wound healing, and taste. Manganese: rare nutritionally; more often a laboratory artefact or contamination issue.

Note: Blood metal levels are exposure markers, not diagnoses; interpret in the clinical and occupational context. Use trace-element–free collection tubes to avoid contamination. For arsenic, speciation (inorganic vs organic) is essential. For copper and zinc, correlate with caeruloplasmin, albumin, and inflammatory markers. Serial results and trend matter more than a single value. Chelation decisions rest on the combination of blood level, symptoms, and source control, not the number alone.

Frequently asked questions

Blood metals reflect recent or circulating exposure with a timeframe of days to weeks, while urine metals integrate longer-term body burden and renal excretion. For arsenic and cadmium, urine is often more informative; for lead and mercury, both specimens are complementary.

How to access the Blood Metals test

The Blood Metals reference page is free and open to all practitioners. Create a free practitioner account to see pricing, save tests to your list, and generate requisition forms. Verification takes 1–2 business days.

Create Free Account

About this page

Published: October 7, 2026

Last reviewed: October 7, 2026

References:
  1. Agency for Toxic Substances and Disease Registry (ATSDR). Toxicological profiles for lead, mercury, cadmium, arsenic. (2020)
  2. Lanphear BP, et al. Low-level environmental lead exposure and children's intellectual function: an international pooled analysis. Environ Health Perspect. (2005)
  3. Centers for Disease Control and Prevention. CDC response to Advisory Committee on Childhood Lead Poisoning Prevention recommendations (blood lead reference interval). (2012)
  4. European Food Safety Authority (EFSA) panel on contaminants: scientific opinion on arsenic in food and tolerable weekly intake. (2009)
  5. Roberts EA, Schilsky ML; American Association for Study of Liver Diseases (AASLD). Diagnosis and treatment of Wilson disease: an update. Hepatology. (2008)

This content is for licensed healthcare practitioners only and does not constitute medical advice. Clinical decisions should be based on the full clinical picture and not on any single test result.